Shubha Ananthakrishnan, MD

Associate Professor

  • 21 Citations
  • 3 h-Index
20042018
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Shubha Ananthakrishnan is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 11 Similar Profiles
Spironolactone Medicine & Life Sciences
Sulfamethoxazole Drug Combination Trimethoprim Medicine & Life Sciences
Peritoneal Dialysis Medicine & Life Sciences
Sudden Death Medicine & Life Sciences
Dialysis Medicine & Life Sciences
Urinary Anti-Infective Agents Medicine & Life Sciences
Kidney Medicine & Life Sciences
Chronic Renal Insufficiency Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2004 2018

  • 21 Citations
  • 3 h-Index
  • 6 Article
  • 3 Review article
  • 1 Chapter
Open Access
Hypoalbuminemia
B-Cell Chronic Lymphocytic Leukemia
Proteinuria
Cells
Nephrotic Syndrome

Dose Targeting Metrics in Conventional and Intensive Maintenance Dialysis

Ananthakrishnan, S. & Depner, T. A., Nov 1 2016, In : Seminars in Dialysis. 29, 6, p. 471-475 5 p.

Research output: Contribution to journalReview article

Dialysis
Maintenance
Renal Dialysis
Renal Replacement Therapy
Chronic Kidney Failure
7 Citations (Scopus)

Hyperparathyroidism of Renal Disease

Yuen, N. K., Ananthakrishnan, S. & Campbell, M., Jun 1 2016, In : The Permanente journal. 20, 3, p. 78-83 6 p.

Research output: Contribution to journalReview article

Hyperparathyroidism
Kidney
Chronic Renal Insufficiency
Vitamin D
Parathyroidectomy
3 Citations (Scopus)

Treatment of Hyperlipidemia Changes With Level of Kidney Function-Rationale

Ananthakrishnan, S. & Kaysen, G., Jul 1 2016, In : Advances in Chronic Kidney Disease. 23, 4, p. 247-254 8 p.

Research output: Contribution to journalReview article

Hyperlipidemias
Kidney
HDL Lipoproteins
Dialysis
LDL Lipoproteins
Urinary Anti-Infective Agents
Mineralocorticoid Receptor Antagonists
Spironolactone
Hyperkalemia
Sulfamethoxazole Drug Combination Trimethoprim